Location | Total iuc+ | Notable clone/s | iuc allele | N iuc (% of iuc/site) | ICEKp (N) | iro allele (N) | rmpA/2 (N) | ESBL/CP (N) |
---|---|---|---|---|---|---|---|---|
Hong Kong | 6 (22%) | ST45 | iuc3 | 1 (17%) | ICEKp4 (1) | – | – | CTX-M-3 (1) |
Vietnam | 34 (43%) | * ST23 | iuc1 | 13 (38%) | ICEKp10a (10) ICEKp3 (1) | iro1 (13) | (10) | CTX-M-14 (1) |
* ST25 | iuc3 | 2 (6%) | ICEKp1 (2) | iro3 (2) | (2) | – | ||
iuc1 | 1 (3%) | – | iro1 (1) | (1) | – | |||
* ST65 | iuc1 | 2 (6%) | ICEKp10 a (1) | iro1 (2) | (2) | CTX-M-15, VEB-1 (1) | ||
Thailand | 0 | – | – | – | – | – | – | |
Laos | 23 (38%) | * ST23 | iuc1 | 10 (44%) | ICEKp10 a (10) | iro1 (10) | (10) | CTX-M-63 (1) |
* ST65 | iuc1 | 2 (6%) | ICEKp10 a (2) | iro1 (3) | (3) | – | ||
* ST86 | iuc1 | – | ICEKp4 (1) | iro1 (3) | (3) | – | ||
ST592 | iuc1 | 10 (44%) | – | iro1 (3) | (3) | – | ||
Cambodia | 4 (10%) | – | – | – | – | – | – | – |
Nepal | 3 (9%) | ST15 | iuc1 | 2 (67%) | ICEKp12 (2) | – | (2) | CTX-M-15 (2) OXA-232 (1) |
India | 24 (28%) | ST231 | iuc5 | 12 (50%) | ICEKp5 (12) | – | – | CTX-M-15 (8) OXA-232 (8) |
iuc ukn | 2 (8%) | ICEKp5 (2) | – | – | CTX-M-15 (2) OXA-232 (2) | |||
ST2096 | iuc1 | 3 (13%) | ICEKp5 (2) | iro1 (1) | – | CTX-M-15 (2) | ||
* ST23 | iuc1 | 2 (8%) | ICEKp3 (1) ICEKp10 a (1) | iro1 (2) | (1) | CTX-M-15 (1) | ||
ST11 | iuc1 | 1 (48%) | ICEKp12 (1) | – | – | CTX-M-15, OXA-232 (1) |